Galectin Therapeutics Inc is a biotechnology business based in the US. Galectin Therapeutics shares (GALT) are listed on the NASDAQ and all prices are listed in US Dollars. Galectin Therapeutics employs 6 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Galectin Therapeutics
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – GALT – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
Galectin Therapeutics stock price (NASDAQ: GALT)Use our graph to track the performance of GALT stocks over time.
Galectin Therapeutics shares at a glance
|Latest market close||$3.97|
|52-week range||$1.91 - $5.70|
|50-day moving average||$3.29|
|200-day moving average||$2.91|
|Wall St. target price||$14.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.42|
Buy Galectin Therapeutics shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Galectin Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Galectin Therapeutics price performance over time
|1 week (2021-07-15)||N/A|
|1 month (2021-06-25)||15.07%|
|3 months (2021-04-26)||-9.15%|
|6 months (2021-01-22)||N/A|
|1 year (2020-07-22)||N/A|
|2 years (2019-07-22)||N/A|
|3 years (2018-07-22)||N/A|
|5 years (2016-07-22)||N/A|
Galectin Therapeutics financials
|Gross profit TTM||$0|
|Return on assets TTM||-48.83%|
|Return on equity TTM||-86.07%|
|Market capitalisation||$159.8 million|
TTM: trailing 12 months
Shorting Galectin Therapeutics shares
There are currently 2.7 million Galectin Therapeutics shares held short by investors – that's known as Galectin Therapeutics's "short interest". This figure is 40.6% down from 4.6 million last month.
There are a few different ways that this level of interest in shorting Galectin Therapeutics shares can be evaluated.
Galectin Therapeutics's "short interest ratio" (SIR)
Galectin Therapeutics's "short interest ratio" (SIR) is the quantity of Galectin Therapeutics shares currently shorted divided by the average quantity of Galectin Therapeutics shares traded daily (recently around 676422.88557214). Galectin Therapeutics's SIR currently stands at 4.02. In other words for every 100,000 Galectin Therapeutics shares traded daily on the market, roughly 4020 shares are currently held short.
However Galectin Therapeutics's short interest can also be evaluated against the total number of Galectin Therapeutics shares, or, against the total number of tradable Galectin Therapeutics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Galectin Therapeutics's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 Galectin Therapeutics shares in existence, roughly 50 shares are currently held short) or 0.0643% of the tradable shares (for every 100,000 tradable Galectin Therapeutics shares, roughly 64 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Galectin Therapeutics.
Find out more about how you can short Galectin Therapeutics stock.
Galectin Therapeutics share dividends
We're not expecting Galectin Therapeutics to pay a dividend over the next 12 months.
Have Galectin Therapeutics's shares ever split?
Galectin Therapeutics's shares were split on a 1:6 basis on 22 March 2012. So if you had owned 6 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Galectin Therapeutics shares – just the quantity. However, indirectly, the new 500% higher share price could have impacted the market appetite for Galectin Therapeutics shares which in turn could have impacted Galectin Therapeutics's share price.
Galectin Therapeutics share price volatility
Over the last 12 months, Galectin Therapeutics's shares have ranged in value from as little as $1.91 up to $5.7. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Galectin Therapeutics's is 2.3205. This would suggest that Galectin Therapeutics's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Galectin Therapeutics overview
Galectin Therapeutics Inc. , a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is (GR-MD-02) belapectin galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial for the treatment of liver fibrosis associated with fatty liver disease and non-alcoholic steatohepatitis cirrhosis, as well as for the treatment of cancer. It also engages in developing GM-CT-01, which is in pre-clinical development stage for the treatment of cardiac and vascular fibrosis, as well as focuses on developing belapectin for the treatment of psoriasis, and lung and kidney fibrosis. The company, through its Galectin Sciences, LLC, which is a collaborative joint venture co-owned by SBH Sciences, Inc. , to research and development of small organic molecule inhibitors of galectin-3 for oral administration. The company was formerly known as Pro-Pharmaceuticals, Inc.
Stocks similar to Galectin Therapeutics
Galectin Therapeutics in the news
How Much Of Galectin Therapeutics Inc. (NASDAQ:GALT) Do Insiders Own?
26 Stocks Moving in Wednesday's Pre-Market Session
64 Biggest Movers From Yesterday
Frequently asked questionsWhat percentage of Galectin Therapeutics is owned by insiders or institutions?
Currently 28.596% of Galectin Therapeutics shares are held by insiders and 17.174% by institutions. How many people work for Galectin Therapeutics?
Latest data suggests 6 work at Galectin Therapeutics. When does the fiscal year end for Galectin Therapeutics?
Galectin Therapeutics's fiscal year ends in December. Where is Galectin Therapeutics based?
Galectin Therapeutics's address is: 4960 Peachtree Industrial Boulevard, Norcross, GA, United States, 30071 What is Galectin Therapeutics's ISIN number?
Galectin Therapeutics's international securities identification number is: US3632252025 What is Galectin Therapeutics's CUSIP number?
Galectin Therapeutics's Committee on Uniform Securities Identification Procedures number is: 363225103
More guides on Finder
How to buy Clover Finance (CLV) in the US
This guide will show you step-by-step instructions on how to buy the Clover Finance (CLV) token as well as a list of exchanges you can trade it on.
How to buy AT-and-T (T) stock
Steps to owning and managing T, with 24-hour and historical pricing before you buy.
How to buy Hellenic Coin (HNC) in the US
This guide will show you step-by-step instructions on how to buy the Hellenic Coin (HNC) token as well as a list of exchanges you can trade it on.
How to buy Maro (MARO) in the US
This guide will show you step-by-step instructions on how to buy the Maro (MARO) token as well as a list of exchanges you can trade it on.
How to buy Ethernity Chain (ERN) in the US
This guide will show you step-by-step instructions on how to buy the Ethernity Chain (ERN) token as well as a list of exchanges you can trade it on.
How to buy Shopping.io (SPI) in the US
This guide will show you step-by-step instructions on how to buy the Shopping.io (SPI) token as well as a list of exchanges you can trade it on.
How to buy LUKSO Token (LYXE) in the US
This guide will show you step-by-step instructions on how to buy the LUKSO Token (LYXE) token as well as a list of exchanges you can trade it on.
How to buy KardiaChain (KAI) in the US
This guide will show you step-by-step instructions on how to buy the KardiaChain (KAI) token as well as a list of exchanges you can trade it on.
How to buy Neutrino USD (USDN) in the US
This guide will show you step-by-step instructions on how to buy the Neutrino USD (USDN) token as well as a list of exchanges you can trade it on.
How to buy Venus BTC (VBTC) in the US
This guide will show you step-by-step instructions on how to buy the Venus BTC (VBTC) token as well as a list of exchanges you can trade it on.
Ask an Expert